159 related articles for article (PubMed ID: 7236992)
21. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
22. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
Pearce PH; Wright JM; Egan CM; Scrutton MC
Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
[TBL] [Abstract][Full Text] [Related]
23. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha.
Armstrong RA; Jones RL; Wilson NH
Prostaglandins; 1985 Apr; 29(4):601-10. PubMed ID: 2988022
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
26. Endothelin and platelet function.
Ohlstein EH; Storer B; Nambi P; Given M; Lippton H
Thromb Res; 1990 Mar; 57(6):967-74. PubMed ID: 2116686
[TBL] [Abstract][Full Text] [Related]
27. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
28. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
Egan CM; Fisher AP; Scrutton MC
Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of agonist-induced platelet aggregation, Ca2+ mobilization and granule secretion by guanosine 5'-[beta-thio]diphosphate and GDP in intact platelets. Evidence for an inhibitory mechanism unrelated to the inhibition of G-protein-GTP interaction.
Krishnamurthi S; Patel Y; Kakkar VV
Biochem J; 1988 Feb; 250(1):209-14. PubMed ID: 3355512
[TBL] [Abstract][Full Text] [Related]
30. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets.
Takano S; Itagaki S; Sakurai K; Suzuki T
Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547
[TBL] [Abstract][Full Text] [Related]
31. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
Glass F; Lippton H; Kadowitz PJ
Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
[TBL] [Abstract][Full Text] [Related]
32. The effects of amrinone on human platelet aggregation: evidence that amrinone does not act through a cyclic nucleotide mechanism in platelet rich plasma.
Lippton HL; Horwitz PM; McNamara DB; Ignarro LJ; Landry AZ; Hyman AL; Kadowitz PJ
Prostaglandins Leukot Med; 1985 May; 18(2):193-204. PubMed ID: 3925461
[TBL] [Abstract][Full Text] [Related]
33. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
34. Platelet activation induced by a stable analogue of endoperoxides (U46619).
Zatta A; Prosdocimi M
Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
[No Abstract] [Full Text] [Related]
35. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
36. Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate.
Hall DA; Frost V; Hourani SM
Biochem Pharmacol; 1994 Oct; 48(7):1319-26. PubMed ID: 7945429
[TBL] [Abstract][Full Text] [Related]
37. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
Le Breton GC; Venton DL; Enke SE; Halushka PV
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066
[TBL] [Abstract][Full Text] [Related]
38. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
Antonikov IM; Alekseev OV; Chernukh AM
Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
[TBL] [Abstract][Full Text] [Related]
39. Facile synthesis of 2-[(3-aminopropyl)thio]adenosine 5'-diphosphate: a key intermediate for the synthesis of molecular probes of adenosine 5'-diphosphate function.
Jefferson JR; Hunt JB; Jamieson GA
J Med Chem; 1987 Nov; 30(11):2013-6. PubMed ID: 3669009
[TBL] [Abstract][Full Text] [Related]
40. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
